Russians are cautious about modern technologies, including biomedicine achievements in biomedicine, suggests a poll conducted by researchers at the National Research University Higher School of Economics (HSE) in Russia.
Researchers polled 1,671 Russians over 16 years of age in 137 settlements across the country.
Those polled neither completely reject, nor accept novelties and consider the interference in human's life deprecated, according to Yury Voynilov and Valentina Polyakova, researchers at HSE Institute for Statistical Studies and Economics of Knowledge (ISSEK).
"The most cautious attitude has been demonstrated by respondents to biotechnologies implying the intervention into the human life and activities by means of stem cells, gene engineering, or implantable devices. These ideas have gained between 22 and 31 per cent of popularity," experts said.
According to the poll, most Russians consider biological novelties useless or even unethical. At the same time, they are concerned about the problems, which can be solved using innovations.
For example, 78 per cent of those polled are anxious about the birth of children with transmittable diseases, but only 30 per cent said they are ready to take genetic tests.
About 90 per cent of respondents are worried about air and water pollution, but only 48 per cent of them said they would like to use pollution alert sensor.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
